Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device

Age-related Macular Degeneration (AMD) Clinical Trial

Official title:

Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02445313
• Other study ID #: NIDEKMP3
• Status: Completed
• Start date: June 2015
• Est. completion date: February 12, 2019

Study information

• Verified date: February 2019
• Source: Doheny Image Reading Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.

Description:

To test the quality of images from the Nidek MP-3 device and to measure Geographic Atrophy (GA) in patients with Age-related Macular Degeneration (AMD).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: February 12, 2019
• Est. primary completion date: February 12, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Normal, healthy participants and patients with AMD

Exclusion Criteria:

1. Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging

2. Participants who are unable to maintain retinal fixation on a specified target

3. Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place

4. Patients with media opacity which preclude high quality imaging will be excluded.

5. Exclusion criteria include vulnerable patients; patients under 18, pregnant, economically and educationally disadvantaged, decision impaired, or homeless people. We exclude pregnant women because pregnancy often can alter eye anatomy.

Related Conditions & MeSH terms

• Age-related Macular Degeneration (AMD)
• Atrophy
• Geographic Atrophy
• Macular Degeneration

Intervention

Device:
• Nidek MP-3
Nidek MP-3 device to be used to take images which will allow measurement of GA in patients with AMD

Locations

Country	Name	City	State
United States	Doheny Eye Centers UCLA	Pasadena	California

Sponsors (1)

Lead Sponsor	Collaborator
Doheny Image Reading Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Geographic Atrophy		1 year